Webcam Delivery of the Camperdown Program for Adolescents Who Stutter: A Phase II Trial

被引:38
|
作者
Carey, Brenda [1 ]
O'Brian, Sue [1 ]
Lowe, Robyn [1 ]
Onslow, Mark [1 ]
机构
[1] Univ Sydney, Australian Stuttering Res Ctr, Sydney, NSW 2006, Australia
关键词
stuttering; adolescents; Camperdown Program; telehealth; LONG-TERM; CLINICAL-TRIAL; SPEECH; ADULTS; SEVERITY; CHILDREN; RELIABILITY; STEREOTYPES; ATTITUDES; THERAPY;
D O I
10.1044/2014_LSHSS-13-0067
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Purpose: This Phase II clinical trial examined stuttering adolescents' responsiveness to the Webcam-delivered Camperdown Program. Method: Sixteen adolescents were treated by Webcam with no clinic attendance. Primary outcome was percentage of syllables stuttered (%SS). Secondary outcomes were number of sessions, weeks and hours to maintenance, self-reported stuttering severity, speech satisfaction, speech naturalness, self-reported anxiety, self-reported situation avoidance, self-reported impact of stuttering, and satisfaction with Webcam treatment delivery. Data were collected before treatment and up to 12 months after entry into maintenance. Results: Fourteen participants completed the treatment. Group mean stuttering frequency was 6.1 %SS (range, 0.7-14.7) pretreatment and 2.8 %SS (range, 0-12.2) 12 months after entry into maintenance, with half the participants stuttering at 1.2 %SS or lower at this time. Treatment was completed in a mean of 25 sessions (15.5 hr). Self-reported stuttering severity ratings, self-reported stuttering impact, and speech satisfaction scores supported %SS outcomes. Minimal anxiety was evident either pre- or post-treatment. Individual responsiveness to the treatment varied, with half the participants showing little reduction in avoidance of speech situations. Conclusions: The Webcam service delivery model was appealing to participants, although it was efficacious and efficient for only half. Suggestions for future stuttering treatment development for adolescents are discussed.
引用
收藏
页码:314 / 324
页数:11
相关论文
共 50 条
  • [21] Phase II trial of web-based tailored asthma management intervention in adolescents at clinics
    Lu, Mei
    Zhang, Talan
    Ownby, Dennis R.
    Zoratti, Edward
    Johnson, Dayna A.
    William, Renee
    Miree, Cheryl
    Joseph, Christine L. M.
    CONTEMPORARY CLINICAL TRIALS, 2019, 82 : 46 - 52
  • [22] Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
    Thomas, Melanie B.
    Morris, Jeffrey S.
    Chadha, Romil
    Iwasaki, Michiko
    Kaur, Harmeet
    Lin, Elinor
    Kaseb, Ahmed
    Glover, Katrina
    Davila, Marta
    Abbruzzese, James
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (06) : 843 - 850
  • [23] Phase II trial evaluating efficacy of a Fitbit program for improving the health of endometrial cancer survivors
    Rahimy, Elham
    Usoz, Melissa
    von Eyben, Rie
    Fujimoto, Dylann
    Watanabe, Darla
    Karam, Amer
    Jairam-Thodla, Arati
    Mills, Margaret
    Dorigo, Oliver
    Diver, Elisabeth Jenefer
    Teng, Nelson
    English, Diana
    Kidd, Elizabeth
    GYNECOLOGIC ONCOLOGY, 2021, 161 (01) : 275 - 281
  • [24] Phase II Trial Evaluating Efficacy of a Fitbit Program for Improving the Health of Endometrial Cancer Survivors
    Rahimy, Elham
    Usoz, Melissa
    von Eyben, Rie
    Fujimoto, Dylann
    Watanabe, Darla
    Karam, Amer
    Jairam-Thodla, Arati
    Mills, Margaret
    Dorigo, Oliver
    Diver, Elisabeth
    Teng, Nelson
    English, Diana
    Kidd, Elizabeth
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S13 - S13
  • [25] Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial
    Marchetti, Marcello
    Pinzi, Valentina
    Iezzoni, Cecilia
    Morlino, Sara
    Tramacere, Irene
    De Martin, Elena
    Cane, Irene
    Fariselli, Laura
    JOURNAL OF NEURO-ONCOLOGY, 2022, 157 (03) : 397 - 403
  • [26] Phase II trial of vatalinib in patients with advanced or metastatic pancreatic adenocarcinoma who failed gemcitabine therapy
    Dragovich, T.
    Laheru, D. A.
    Crowley, J. J.
    Smith, L. S.
    Seng, J.
    Burris, H. A., III
    Rosen, P. J.
    Von Hoff, D. D.
    Bolejack, V.
    Hidalgo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial
    Marcello Marchetti
    Valentina Pinzi
    Cecilia Iezzoni
    Sara Morlino
    Irene Tramacere
    Elena De Martin
    Irene Cane
    Laura Fariselli
    Journal of Neuro-Oncology, 2022, 157 : 397 - 403
  • [28] Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer
    Lustberg, Maryam B.
    Povoski, Stephen P.
    Zhao, Weiqiang
    Ziegler, Rebecca M.
    Sugimoto, Yasuro
    Ruppert, Amy S.
    Lehman, Amy M.
    Shiels, Donna R.
    Mrozek, Ewa
    Ramaswamy, Bhuvaneswari
    Layman, Rachel M.
    Brueggemeier, Robert W.
    Shapiro, Charles L.
    CLINICAL BREAST CANCER, 2011, 11 (04) : 221 - 227
  • [29] Lidcombe Program telehealth treatment for children 6-12 years of age: A Phase II trial
    Johnson, Georgina
    Onslow, Mark
    Carey, Brenda
    Jones, Mark
    Kefalianos, Elaina
    JOURNAL OF FLUENCY DISORDERS, 2024, 80
  • [30] The feasibility of a physical activity program for young adults with Down syndrome: A phase II randomised controlled trial
    Shields, Nora
    Taylor, Nicholas F.
    JOURNAL OF INTELLECTUAL & DEVELOPMENTAL DISABILITY, 2015, 40 (02): : 115 - 125